TrialThe New England journal of medicine2009
Denosumab in men receiving androgen-deprivation therapy for prostate cancer.
Matthew R Smith et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
408 papers cite itlatest 60 shown
this paperpooled ittrialcites it